CSNK2B and malignant colon neoplasm: Importantly, we experimentally validated two C-to-U RESs, in CSNK2B (casein kinase II beta subunit) and RPS14 (ribosomal protein S14), respectively, with different impacts on cell proliferation in colon cancer.